Abstract The aim of this study is to establish the effectiveness of a clinical case management (CM) programme compared to a standard treatment programme (STP) in patients with schizophrenia. Patients for the CM programme were consecutively selected among patients in the STP with schizophrenia who had poor functioning. Seventy-five patients were admitted to the CM programme and were matched to 75 patients in the STP. Patients were evaluated at baseline and at 1 year follow-up. At baseline, patients in the CM programme showed lower levels of clinical and psychosocial functioning and more care needs than patients in the STP. Both treatment programmes were effective in maintaining contact with services but the CM programme did not show advantages over the STP on outcomes. Differences between groups at baseline may be masking the effects of CM at one year follow-up. A longer follow-up may be required to evaluate the real CM practices effects.
Introduction
Case management (CM) is one of the main components of the services for persons with severe mental disorders (SMDs). Although CM was initially defined as a way of coordinating resources for a patient, nowadays, case manager activities are broader and usually include the direct provision of services (Mueser et al. 1998) . CM is successful in community-based models (Marshall et al. 2000; Mueser et al. 1998; Van Os 2009; Ziguras and Stuart 2000) in outcomes such as treatment compliance, hospital admissions, satisfaction and quality of life (QoL).
For the Research Group on Severe Mental Disorder.
In Spain, where mental health care is community-based, CM has proven to be cost-effective in decreasing the burden of schizophrenia (Gutiérrez-Recacha et al. 2006 ) and use of services (Alonso Suárez et al. 2011) . In Catalonia, a Spanish autonomous community, a new model of mental health care was developed during the transition to democracy. It led to a public mental health network integrated into the national health system, organised into health care sectors and based on Adult Mental Health Centres (AMHCs) and hospitals and community rehabilitation centres. AMHCs consist of multidisciplinary teams (psychiatrists, psychologists, nurses and social workers) that offer outpatient and specialist care for mental disorders through programmes and interventions included in their care services during office hours. Since their establishment, AMHCs offer care to patients with SMDs through a Standard Treatment Program (STP) that includes: (1) general clinical and psychosocial assessments; and (2) medical interventions and follow-ups.
In 1997, the Health Department of Catalonia developed a specific type of CM programme for patients with SMDs that requires a higher level of care and other resources in addition to those in the STP. Its elements are those described by Ruggeri and Tansella (2008) and it meets the criteria of a clinical CM model by offering direct provision of care, and of a non-intensive CM programme since the caseload size is over 20 patients (Dieterich et al. 2010) . The STP and the CM programme have been described in detail elsewhere (Mas-Expósito et al. 2013 ) and all interventions in both programmes follow the Clinical Practice Guideline for Schizophrenia (Working group of the clinical practice guideline for schizophrenia and incipient psychotic disorder 2009).
Studies on the effects of CM in Spain are scarce, have been conducted without control groups and are restricted to specific outcomes (Alonso Suárez et al. 2011; Gutiérrez-Recacha et al. 2006) . This paper deals with these issues by establishing the effectiveness of a clinical CM programme versus a STP regarding clinical, psychosocial and service use variables.
Methods
A quasi-experimental study, pre-post, two groups, one quasi-control, was used.
Participants
The sample was composed of 150 patients (67.3 % males; 75 in the CM programme and 75 in the STP). Seventy percent of patients in both programmes had illness duration longer than 10 years, 66.7 % of them had diagnosis of paranoid schizophrenia and their mean age was 41.47 years (SD = 11.80). There were significant differences between the study groups in the type of housing they lived in. A lower percentage of patients in the CM programme reported to live in family-owned housing [CM = 43 (57.3 %) , STP = 60 (80 %), v 2 (2) = 9.83, p = 0.007]. No other differences concerning socio-demographic variables were found between both study groups (all p values [ 0.05).
Patients were recruited from December 2006 to January 2008 from 10 AMHCs in Barcelona (Catalonia, Spain). All patients had: (1) diagnosis of schizophrenia according to the International Classification of Diseases-10 or ICD-10 (World Health Organization 1995), (2) illness duration greater than 2 years and (3) clinical stability at assessment time. Patients were excluded if they had dementia, organic brain injury or intellectual disability. Patients for the CM programme were consecutively selected among those in the STP visiting the AMHCs with a Global Assessment of Functioning (GAF) total score B50 (Endincott 1976) . Patients in the STP were selected from the AMHC databases through an intentional non-probabilistic sampling among all patients in the STP that could be matched with the patients selected for the CM programme regarding: age (±5 years), gender, illness length (±5 years) and symptoms by the Positive and Negative Syndrome Scale (PANSS; Kay et al. 1987 ; PANSS total score, ±10 points). There were no significant differences between groups regarding psychiatric symptoms at baseline (PANSS total: CM = 87.59, STP = 85.87, t = 0.851, p = 0.396; PANSS positive: CM = 17.60, STP = 17.08, t = 0.669, p = 0.504; PANSS negative: CM = 25.64, STP = 25.15, t = 0.537, p = 0.592; PANSS general: CM = 44.35, STP = 43.64, t = 0.560, p = 0.576).
Instruments
Patients were assessed at baseline and at one year followup with these instruments:
The Schizophrenia Cost Evaluation Questionnaire (Haro et al. 1998) . It records on the use of health care and social services.
The GAF (Endincott 1976 ). This is a valid measure of psychological functioning in persons with SMD included in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association 1994).
The PANSS (Kay et al. 1987) . It assesses symptom severity in persons with schizophrenia. Its validation into Spanish shows good psychometric properties (Peralta and Cuesta 1994) .
The Disability Assessment Schedule short version (DAS-s; Janca et al. 1996) . It is a valid and reliable measure of functioning for mental disorders included in the ICD-10 (World Health Organization 1995) validated in persons with schizophrenia (Mas-Expósito et al. 2012a) .
The Camberwell Assessment of Needs (CAN; Phelan et al. 1999) . It measures the needs of people with mental illness and shows good psychometric properties in persons with schizophrenia (Rosales et al. 2002) .
The World Health Organization Quality of Life Scale Brief Version (WHOQOL-BREF; World Health Organization 1993). It is an international, cross-culturally analogous QoL instrument that shows good psychometric properties in persons with schizophrenia (Mas-Expósito et al. 2011) .
The modified DUKE-UNC Functional Social Support Questionnaire (FSSQ; Broadhead et al. 1988) . It measures the strength of social networks. The Spanish version shows good psychometric properties in primary care patients (Bellón-Saameño et al. 1966 ) and in patients with schizophrenia (Mas-Expósito et al. 2012b ).
Procedure
Each AMHC provided both programmes. The AMHC teams performed patient assessments. For both programmes, the psychiatrists established the diagnosis, following the ICD-10 (World Health Organization 1995) research diagnosis criteria and considered self and caregiver reports, and assessed psychiatric symptoms. The rest of assessments were performed by the other members of the teams under the psychiatrist's supervision or by a community psychiatric nurse from the teams in the STP. The psychiatrist was responsible for setting up and supervising the assessment agenda and sending the score sheets to the psychologist who designed and analysed the database.
To guarantee quality data, the psychiatrists participated in a schizophrenia diagnostic consensus workshop comprising two case studies. All researchers were trained in the instruments in a 4-h session run by a clinical psychologist. Systematic reviews of data coding and recording were made and patient information was compared with data from the AMHC responsible for each patient.
Statistical Analysis
Clinical and psychosocial outcomes and use of health services were analysed using the Statistical Package for the Social Sciences v. 19. Chi-square analysis and Student's t-tests for independent samples were used for categorical and continuous data, respectively. Mann-Whitney U tests were applied for continuous data to compare independent samples with fewer than 30 patients.
Ethical Considerations
The study was approved by the Ethics Committee of the Catalan Union of Hospitals and carried out in accordance with the ethical standards of the 1964 Declaration of Helsinki. The procedures were described to each patient who then provided informed consent.
Results
A total of 69 patients (92 %) in the CM programme were successfully followed up. Four individuals (out of 6) had no contact with services, 1 refused to participate and 1 died by suicide. Regarding the STP, 69 patients (92 %) were successfully followed up. Six patients had no contact with services. No significant differences between study groups were observed regarding treatment attrition (v 2 (1) = 0.000; p [ 0.05).
At baseline, no significant differences were found between the CM programme and the STP groups in disability, subjective QoL regarding psychological health, social relationships and environment, and perceived social support (all p values [ 0.05). However, there were significant differences between groups in patients' needs from the clinician's point of view [CM = 9.14 (7.43), STP 
Discussion
This paper aimed to establish the effectiveness of a CM programme versus a STP regarding clinical, psychosocial and service use variables.
Both programmes were effective in maintaining contact with services. Only eight per cent of patients in each programme lost contact with services, which concurs with Marshall et al. (2000) with regard to the efficacy of CM and points out favourable effects regarding the STP.
Case management did not show advantages over the STP on the clinical and psychosocial outcomes considered. Therefore, our results seem to coincide with those in a meta analyses conducted by Marshall et al. (2000) on the efficacy of CM versus standard care. Namely, the results of this meta analyses showed no benefit of CM over standard care on functioning, QoL, needs, self-esteem, satisfaction and psychological well-being. Even so, a closer examination of our figures may be pointing out different conclusions. Throughout the study, it seems there was a tendency to clinical improvement in the CM group, which could be masked because of baseline differences between groups. When we look at needs scores we realize that, at one-year follow-up, the CM group reduced its level of needs by about two points [baseline = 9.14 (7.43); one year followup = 7.89 (3.56)] while the STP group kept the same baseline level [baseline = 7.43 (3.32); one year followup = 7.01 (2.80)]. The same trend is observed on QoL concerning physical health. As for the rest of variables (i.e. clinical and social functioning and overall QoL) both treatment programmes seemed to improve but those improvements seemed greater for the CM group. For instance, the improvement in clinical functioning of the CM group [baseline = 42.03 (7.15); one year followup = 46.65 (11.20)] was twice than that observed in the STP [baseline = 47.01 (8.71); one year follow-up = 49.14 (10.46)]. When looking at the results in this way, our findings coincide with those in a meta-analyses on the effectiveness of clinical CM versus usual treatment in clinical functioning (Ziguras and Stuart 2000) and in other reviews (Mueser et al. 1998 ). Our results coincide as well with those from other studies (Lichtenberg et al. 2008 ) that found improvements in subjective QoL but with a nonvalidated scale. We used the WHOQOL-BREF (World Health Organization 1993) which has good psychometric properties in persons with schizophrenia (Mas-Expósito et al. 2011). To our knowledge, this is the first study conducted in Spain dealing with this relevant outcome (Van Esch et al. 2012) . Our results also suggest that CM was associated with decreasing health care needs. It is important highlighting that needs are considered a key component for the recovery of this sample population (Werner 2012) . Studies are needed to see whether our findings are replicated and a longer follow-up period might be required to determine CM effects (Lichtenberg et al. 2008) .
Case management did not show advantages over the STP on use of health care services but, even so, it is worth to make some considerations since, again, baseline differences could be masking CM effects. At 1 year follow-up, most of baseline between-group differences were not present anymore. If we look in detail at the proportion of patients that used inpatient hospital services [baseline = 24 (32.0 %); 1 year follow-up = 11 (15.9 %)] and emergency services [baseline = 17 (22.7 %); 1 year follow-up = 9 (13.0 %)] in the CM group, we realize that it was reduced by half. Our results seem to contradict CM studies in other settings where CM is associated with increasing hospitalisation (Marshall et al. 2000; Ziguras and Stuart 2000) . Nevertheless, they concur with Spanish studies about the effectiveness of clinical CM (Alonso Suárez et al. 2011 ) that show a drop in the number of hospitalised patients which is similar to that observed in our study. Alonso Suárez et al. (2011) also showed a significant decrease in the number of patients visiting emergency rooms. To our knowledge, ours is the second study conducted regarding this outcome. One should also take into account that the STP group also reduced about the same the use of inpatient hospital services [baseline = 12 (16.0 %); 1 year follow-up = 6 (8.7 %)] and emergency services [baseline = 8 (10.7 %); 1 year follow-up = 3 (4.3 %)]. Even so, the reduction observed in the CM group seems enough to decrease differences with the STP at oneyear follow-up. Considering that both groups had different levels of clinical stability at baseline, we would like to suggest a longer follow-up to evaluate CM effects at medium or long-term. At follow-up, the CM group still used more social services, which may be associated to their poorer social functioning at both assessment points and there were new differences regarding some health care services. A higher proportion of patients in the CM programme group used overall outpatient hospital services [CM = 12 (17.4 %); STP = 3 (4.3 %)], while a higher proportion of patients in the STP group used primary care nursing services [CM = 17 (24.6 %); STP = 28 (40.60 %)]. One possible explanation might be that, after the follow-up, patients were ready to use less intensive services. At baseline, the CM group made more visits to outpatient hospital services, outpatient psychiatric hospital services, community psychiatric services and community psychiatric nursing services. At 1 year follow up, the CM programme group only showed more community psychiatric nursing visits. There was an increase of visits in the CM programme group [baseline = 7.81 (7.48); 1 year follow-up = 11.64 (8.35)] not observed in the STP [baseline = 4.42 (5.38); 1 year follow-up = 4.94 (5.97)], which coincides with the metanalyses of Ziguras and Stuart (2000) that shows that clinical CM increases contact with services. The increase of such visits in the CM group might have turned into a decrease of outpatient psychiatric hospital service visits [baseline = 8.40 (11.24); 1 year follow-up = 2.17 (1.75)]. Hospital service use was quite low, which contradicts the hypothesis that CM is effective where hospital bed use is high (Burns et al. 2007 ) but coincides with other Spanish studies (Alonso Suárez et al. 2011) .
Although the aforementioned strengths when comparing our study with other Spanish studies, our results are limited to a 1 year follow-up. As suggested by some authors (Björk-mann and Hansson 2007), certain outcomes regarding CM practices for persons with SMD do not appear in a short-term perspective (i.e. between 6 and 24 months). In addition, we did not use psychosocial variables as a matching group criteria, which could be associated with the existence of the between-group differences observed at baseline and, thus, with the limitations of using a quasi-experimental design. Even so, it is worth highlighting that there were no betweengroup differences on the matching group criteria used at baseline (i.e. age, gender, illness length and psychiatric symptoms) and that quasi-experimental designs are considered to be appropriate in clinical and ordinary settings, such as that in this study (Campbell and Stanley 1966) . Further research may consider new components in the CM programme such as an adjunct exercise programme, which has been considered feasible for coping with the high rates of morbidity and mortality in persons with schizophrenia (Sylvia et al. 2012) . Other factors that further research may consider when evaluating CM effects is patient perceived criticism. It has been positively associated to higher levels of psychiatric symptoms (Guada et al. 2011) .
In summary, the CM group did not show advantages over the STP group on clinical and psychosocial outcomes and health care service use. The CM group showed lower levels of clinical and social functioning, and more care needs than the STP group at baseline, which could be masking the results. A longer follow-up is required before drawing conclusions about the effectiveness of those interventions.
